Stay updated on AT1001 Long-term Safety Study in Fabry Disease Clinical Trial

Sign up to get notified when there's something new on the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Minor formatting adjustments and wording clarifications in the Study Details page; no substantive changes to eligibility criteria, outcomes, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:14:54.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    4%
    Check dated 2025-10-06T05:34:29.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:06:32.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:22:51.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T16:10:13.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new information on diseases and treatments such as Fabry disease, larazotide acetate, and migalastat. The revision number has also been updated to v3.0.0.
    Difference
    2%
    Check dated 2025-08-31T12:02:42.000Z thumbnail image

Stay in the know with updates to AT1001 Long-term Safety Study in Fabry Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AT1001 Long-term Safety Study in Fabry Disease Clinical Trial page.